The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2014
DOI: 10.5607/en.2014.23.3.224
|View full text |Cite
|
Sign up to set email alerts
|

The Combination of Antidepressant Duloxetine with Piracetam in Mice does not Produce Enhancement of Nootropic Activity

Abstract: There is a strong association between depression and memory impairment. The present study aims to assess the nootropic activity of duloxetine and piracetam combination. Male Swiss Albino mice were divided randomly into 4 groups. Treatment of normal saline (10 ml/kg), duloxetine (10 mg/kg), piracetam (100 mg/kg), and duloxetine (5 mg/kg) plus piracetam (50 mg/kg) were given through intra-peritoneal route to group I-IV, respectively. Transfer latency in elevated plus maze (EPM) and time spent in target quadrant … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
1
1
0
Order By: Relevance
“…Piracetam was administered at a dose of 300 mg/kg, while Meldonium was administered at a dose of 200 mg/kg. These doses correspond to literature data for Piracetam [87] and Meldonium [88].…”
Section: Biological Activitysupporting
confidence: 87%
“…Piracetam was administered at a dose of 300 mg/kg, while Meldonium was administered at a dose of 200 mg/kg. These doses correspond to literature data for Piracetam [87] and Meldonium [88].…”
Section: Biological Activitysupporting
confidence: 87%
“…For the control group ( N = 24), the same amount of PBS was administered in the same pattern. The dosage of piracetam was determined by referencing previous reports [[28], [29], [30]]. All of the animal handling and treatment protocols were reviewed and approved by the Animal Care and Use Committee of National Institute of Neuroscience, National Center of Neurology and Psychiatry (approval number, 2017010).…”
Section: Methodsmentioning
confidence: 99%